A Systematic Review of Smoking Cessation Intervention Studies in China

Kim, Sun S.; Chen, Wei; Kolodziej, Monika; Wang, Xue; Wang, Victoria J.; Ziedonis, Douglas
August 2012
Nicotine & Tobacco Research;Aug2012, Vol. 14 Issue 8, p891
Academic Journal
Introduction: China has the highest number of tobacco smokers among the world’s nations; however, no systematic review has been conducted of clinical trials on the efficacy of smoking cessation interventions in China. This paper summarizes findings of studies in order to compare the effect of pharmacotherapy, counseling, and Traditional Chinese Medicine (TCM) approaches on the abstinence rate. Methods: Clinical trials of smoking cessation interventions published in English or Chinese were extracted from an electronic search of PubMed and WanFang databases. The search yielded 234 studies from the PubMed and 78 studies from the WanFang. Results: Twenty-nine studies were included in this review. Of these, 11 (37.9%) were randomized controlled trials (RCTs) that assessed the following approaches: counseling (5 studies), TCM (3 studies), pharmacotherapy (1 study), a combination of pharmacotherapy and counseling (1 study), and physician advice (1 study). Pharmacotherapy alone or in combination with counseling generally resulted in a higher abstinence rate than counseling alone. TCM techniques such as acupuncture and ear point seed pressure yielded a much higher abstinence rate than pharmacotherapy and counseling. Findings are inconclusive, however, because most of the TCM studies were noncontrolled trials and did not provide a definition of “abstinence.” Findings on the effectiveness of physician advice to quit smoking were also inconclusive. Conclusions: A review of smoking cessation studies revealed that pharmacotherapy was effective in China. More RCTs of TCM approaches and physician advice are needed with long-term follow-up assessments and biochemical verification of self-reported abstinence before these approaches are adopted as evidence-based smoking cessation interventions in China.


Related Articles

  • A pilot randomised controlled trial of the feasibility of using body scan and isometric exercises for reducing urge to smoke in a smoking cessation clinic. Al-Chalabi, Lemees; Prasad, Neha; Steed, Lucy; Stenner, Sarah; Aveyard, Paul; Beach, Jane; Ussher, Michael // BMC Public Health;2008, Vol. 8 Issue 1, p349 

    Background: The main cause of relapse in smokers attempting to quit is inability to resist urges to smoke. Pharmacotherapy ameliorates but does not entirely prevent urges to smoke when abstinent, so other methods to resist urges to smoke might be helpful. Exercise is effective, but aerobic...

  • Effect of Varying Levels of Disease Management on Smoking Cessation. Ellerbeck, Edward F.; Mahnken, Jonathan D.; Cupertino, A. Paula; Cox, Lisa Sanderson; Greiner, K. Allen; Mussulman, Laura M.; Nazir, Niaman; Shireman, Theresa I.; Resnicow, Kenneth; Ahluwalia, Jasjit S. // Annals of Internal Medicine;4/7/2009, Vol. 150 Issue 7, p437 

    Background: Cigarette smoking is a chronic, relapsing illness that is inadequately addressed in primary care practice. Objective: To compare cessation rates among smokers who receive pharmacotherapy alone or combined with either moderate- or high-intensity disease management that includes...

  • One-Hour Training for General Practitioners in Reducing the Implementation Gap of Smoking Cessation Care: A Cluster-Randomized Controlled Trial. Verbiest, Marjolein E. A.; Crone, Mathilde R.; Scharloo, Margreet; Chavannes, Niels H.; van der Meer, Victor; Kaptein, Ad A.; Assendelft, Willem J. J. // Nicotine & Tobacco Research;Jan2014, Vol. 16 Issue 1, p1 

    Introduction: This study examined the effectiveness of low-intensity, practice-tailored training for general practitioners (GPs) aimed at personal and organizational barriers that arise when routinely asking patients’ smoking status, advising to quit, and arranging follow-up. Methods: A...

  • Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. David, Sean P.; Strong, David R.; Munafò, Marcus R.; Brown, Richard A.; Lloyd-Richardson, Elizabeth E.; Wileyto, Paul E.; Evins, Eden A.; Shields, Peter G.; Lerman, Caryn; Niaura, Raymond; Munafò, Marcus R // Nicotine & Tobacco Research;Dec2007, Vol. 9 Issue 12, p1251 

    We analyzed pooled data from two comparable randomized placebo-controlled clinical trials of bupropion pharmacotherapy for smoking cessation for which data on DRD2 Taq1A genotype were available. A total of 722 smokers across the two trials were randomized to 10 weeks of sustained-release...

  • Smoking cessation pharmacotherapy preferences in rural primary care. Cupertino, Paula A.; Richter, Kimber P.; Cox, Lisa Sanderson; Nazir, Niaman; Greiner, Allen K.; Ahluwalia, Jasjit S.; Ellerbeck, Edward F. // Nicotine & Tobacco Research;Feb2008, Vol. 10 Issue 2, p301 

    Pharmacotherapy is a critical adjunct to smoking cessation therapy. Little is known about relative preferences for these agents among smokers in primary care settings. In the context of a population-based clinical trial, we identified 750 smokers in primary care practices and independent of...

  • Identifying Barriers to Entering Smoking Cessation Treatment Among Socioeconomically Disadvantaged Smokers. Copeland, Amy L.; Businelle, Michael S.; Stewart, Diana W.; Patterson, Scott M.; Rash, Carla J.; Carney, Colleen E. // Journal of Smoking Cessation;Oct2010, Vol. 5 Issue 2, p164 

    Background: Efficacious smoking cessation interventions exist, yet few smokers utilise available resources such as psychosocial treatment programs and pharmacotherapy. The goals of the present study were to (1) identify perceived barriers to entering smoking cessation treatment programs among...

  • Commentary: Putting the research into practice. Rigotti, Nancy A // BMJ: British Medical Journal (International Edition);12/13/2003, Vol. 327 Issue 7428, p1395 

    Comments on putting research on helping smokers quit into practice. The selection of treatments including pharmacotherapy and counselling; Use of nicotine-replacement drugs.

  • The Views and Experiences of Smokers Who Quit Smoking Unassisted. A Systematic Review of the Qualitative Evidence. Smith, Andrea L.; Carter, Stacy M.; Dunlop, Sally M.; Freeman, Becky; Chapman, Simon // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: Unassisted cessation – quitting without pharmacological or professional support – is an enduring phenomenon. Unassisted cessation persists even in nations advanced in tobacco control where cessation assistance such as nicotine replacement therapy, the stop-smoking...

  • Control of Visceral Leishmaniasis in Latin America--A Systematic Review. Romero, Gustavo A. S.; Boelaert, Marleen // PLoS Neglected Tropical Diseases;Jan2010, Vol. 4 Issue 1, p1 

    Background: While three countries in South Asia decided to eliminate anthroponotic visceral leishmaniasis (VL) by 2015, its control in other regions seems fraught with difficulties. Is there a scope for more effective VL control in the Americas where transmission is zoonotic? We reviewed the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics